Navigation Links
Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay
Date:10/2/2008

The Study Will Compare the Results of Rosetta Genomics' microRNA-based Test, miRview(TM) Squamous, Which Differentiates Squamous From non Squamous

non Small Cell Lung Cancer, With Current Diagnostic Methods A Test Based on the miRview(TM) Technology First Approved for Clinical use Through Columbia University's High Complexity Molecular Pathology Lab

Earlier This Year Rosetta Genomics is Expecting to Launch miRview(TM) Squamous Later This

Year Through its Recently Acquired CLIA lab in Philadelphia

REHOVOT, Israel and JERSEY CITY, New Jersey, October 2 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG), a leader in the development of microRNA-based diagnostic and therapeutic products, announced today the initiation of a clinical assessment study with the Johns Hopkins University School of Medicine. The study will compare Rosetta Genomics' miRview(TM) squamous, which differentiates squamous from non squamous non small cell lung cancer, with available immunohistochemistry methods.

"We are excited to be collaborating once more with the excellent scientists at Johns Hopkins University," said Dr. Dalia Cohen. "Having this microRNA-based test assessed for clinical validity by faculty at one of the country's top cancer research centers is viewed by us as a strong indication to the interest this product and our technology are generating in the oncology world."

Differentiating squamous from non squamous cell lung cancer presents a challenge to physicians, but until recently this differentiation was not particularly relevant from a therapeutic or prognostic standpoint since no drug was designed for a specific NSCLC sub-type.

A recently approved angiogenesis inhibitor for NSCLC has been shown to have severe side effects for squamous-cell lung cancer patients. Furthermore, this targeted therapy includes a black-box warning about substantially higher rates of severe or fatal hemo
'/>"/>

SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Duska Therapeutics Licenses Portfolio of Heart Failure Drugs From Duke and Johns Hopkins
2. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
3. Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Societys Annual Meeting
4. Peregrine Announces Addition of The Johns Hopkins Hospital as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV
5. Hopkins Report: Focusing on Family Planning Lessens HIV Impact
6. Queens University Chooses Xceeds Ziplex(R) System for Translational Research
7. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
8. The University of Nottingham in the British Midlands Announces Breakthrough in Parkinsons Disease Research
9. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
10. First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
11. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...TER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedtraditio...non-nucleosidereversetranscriptaseinhibitor(NNRTI)...eintreatment-experiencedadultswhoareexperiencingvi...dotherantiretroviral(ARV)agents.Thetraditionalappr...sDUET-1andDUET-2.INTELENCEiscurrentlymarketedinthe...
(Date:11/25/2009)...IDGE,N.J.,Nov.25/PRNewswire/--RegadoBiosciences,ap...mboticaptamerswithactivecontrolagents,announcedtha...thePiperJaffray21stAnnualHealthCareConferenceatthe...tionwillbegivenat1:10pm(EST)onTuesday,December1and...hasisontheleaddevelopmentprogram,theanticoagulants...
(Date:11/25/2009)...Y,Calif.,Nov.25/PRNewswire-FirstCall/--Abaxis,Inc....ngpoint-of-carebloodanalysissystems,announcedtoday...,willpresentatthe21stAnnualPiperJaffrayHealthCareC...econferencewillbeheldattheNewYorkPalaceHotelinNewY...manufacturesandmarketsportablebloodanalysissystems...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Syngenta Acquires Innovative Bio Control Technology to Improve Usable Crop Yields 12574 1Syngenta Acquires Innovative Bio Control Technology to Improve Usable Crop Yields 12574 2Syngenta Acquires Innovative Bio Control Technology to Improve Usable Crop Yields 12574 3A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 1A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 1Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 3
...tes Recognized as Marker of,Treatment Success -, ...-conducted study being presented at the 59th Annua...y of Liver Diseases (AASLD) shows that,PEGASYS(R) ...in higher,sustained virological response (SVR) rat...s with another pegylated interferon.(1), Comparin...
...,significantly increase the risk of the most commo...ied by researchers at Massachusetts General,Hospit...November 7th issue,of American Journal of Human Ge...s Genome Project" (AGP) established three years ag...genetic risk factors, may lead to more,aggressive ...
Other Medicine Technology:New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 2New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 3New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 4New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 5New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 6New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients 7Breakthrough Mapping of Alzheimer's Genome Helps ID Four New Suspect Genes 2Breakthrough Mapping of Alzheimer's Genome Helps ID Four New Suspect Genes 3
(Date:11/27/2009)...e; announced today that Spectrum Health (Grand Rap...se orthopedic templating solution and its TraumaCa... (PRWEB) November 27, 2009 -- Voyant Health&tr...apids, Michigan) has licensed its TraumaCad Enterp...Cad Extend workflow solution, to allow its orthope...
(Date:11/27/2009)...turers who use medical load cells at the heart of ...ringing in technology partner Flintec early in the...medical manufacturers are calling in Flintec load ...s, ensuring that progress will not be constrained ...ed technology. , (PRWEB) ...
(Date:11/26/2009)...andfluseasonuponus,it,smoreimportantthanevertoempl...oidillness. ,, "Weneedtobeproactivenotonlytokee...e,resick,"saidEileenFinerty,RN,MS,CIC(certifiedini...olandoccupationalhealthatHospitalforSpecialSurgery...asoneofthelowestinfectionratesofanyhospitalintheco...
(Date:11/26/2009)...ans living with diabetes will nearly double, incre... 2034. Over the same period, spending on diabetes ...36 billion, even with no increase in the prevalenc...of Chicago report in the December issue of Diabet...vered by Medicare will rise from 8.2 million to 14...
(Date:11/26/2009)... to strains or worse , , THURSDAY, Nov. ...with stuffing your turkey full to bursting, but yo...itcase as you pack for holiday trips. , More th...ital emergency rooms, doctors, offices, clinics an...uries, such as muscle strains, pulls and tears, ac...
Breaking Medicine News(10 mins):Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Pack Right for the Holidays to Avoid the ER 2
... Health Agency of Canada has reported that two tou..., leading to increased fears that the recent outbr...s in the country's tourist industry. The touri...dians traveling to the island to use anti-malarial...
...chers from Massachusetts and North Carolina have f...lised for treatment of conditions //that have resu...(COPD) such as emphysema, chronic bronchitis recei... treatment guidelines for this condition and none ...
...would be established in the near future for those ...nd HIV/AIDS //. Health Minister Mary Harney s...e introduction of a Bill to address insurance diff...patients especially women. These people suffe...
...Cancer Support of UK has taken a strong campaign a...onducted that said that in Scotland people spent//...al during treatment which is ?318 in Wales. Th...ents in Scotland and the South West can pay almost...
...a is a disease that spreads through mosquitoes. Ac...tion health officials there has been an increase i...bout 123 people are admitted in the hospital showi...ue. The disease is by far concentrated in North Ch...
...f five . Asthma-related deaths per year, in the U...ugs salmeterol or formoterol //. According to res...hese drugs should be taken off the market . Th... who inhaled the long-acting beta-agonists salmete...
Other Medicine News:Health News:Outbreak of Malaria to Lead to Loss in Tourist Industry 2Health News:COPD Patients In US Are Not Receiving 'Ideal Care' 2Health News:Inhaler Linked To Asthma Deaths 2Health News:Inhaler Linked To Asthma Deaths 3
Eppendorf Research Series 2100 Adjustable-volume Pipette, 20-200 l
...or for sub-microliter pipetting and beyond. Offers...adjustable. Features lPLUS, a direct-drive digital...le ejector buttons to fit large hands or tiny hand...ifferent lengths. Air-displacement mechanism. No r...
...bsystems was designed specifically to combine ergo...features such as the new fast dial system with .01...define this as a new leader in single channel pipe...a custom fit for different hand sizes. The new sho...
...tte is a synonym for pipetting accuracy, a smooth ...operating comfort. Its single, multifunctional but...ow-out as well as eject the tip. Product features...ccuracy and precision. Ejection sleeve can be rem...
Medicine Products: